The Infectious Diseases Research Institute (IDRI)

The newly established SingHealth Duke-NUS Infectious Diseases Research Institute (IDRI) seeks to provide leadership, strategic direction and coordination for Infectious Diseases research collaborations between SingHealth and Duke-NUS; to serve as a bridge between SingHealth Infectious Diseases and the Duke-NUS Emerging Infectious Diseases (EID) Programme, and the Academic Medicine Research Institute (AMRI).

SingHealth and Duke-NUS will be each other’s committed partners for Infectious Diseases research in the AMC. IDRI will initiate and form system wide workgroups in strategic areas of Infectious Diseases research, each co-led by a Duke-NUS and SingHealth researcher.

Key Strategies

The Viral Research and Experimental Medicine Centre @ Singhealth Duke-NUS (ViREMiCS) aims to accelerate the translation of drugs and vaccines to combat infectious diseases so as to reduce the time needed for new drugs and vaccines in need during epidemics and outbreaks.